Related references
Note: Only part of the references are listed.Physiologically-Based Pharmacokinetic Modeling for Drug-Drug Interactions of Procainamide and N-Acetylprocainamide with Cimetidine, an Inhibitor of rOCT2 and rMATE1, in Rats
Yoo-Seong Jeong et al.
PHARMACEUTICS (2019)
Rhododendrin-Induced RNF146 Expression via Estrogen Receptor Activation is Cytoprotective Against 6-OHDA-Induced Oxidative Stress
Hyojung Kim et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson's disease
Seung Pil Yun et al.
NATURE MEDICINE (2018)
ER Stress Induced by Tunicamycin Triggers α-Synuclein Oligomerization, Dopaminergic Neurons Death and Locomotor Impairment: a New Model of Parkinson's Disease
Valentin Coppola-Segovia et al.
MOLECULAR NEUROBIOLOGY (2017)
Influence of 6-Hydroxydopamine Toxicity on -Synuclein Phosphorylation, Resting Vesicle Expression, and Vesicular Dopamine Release
Kavina Ganapathy et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2016)
The c-Abl inhibitor, Nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease
Senthilkumar S. Karuppagounder et al.
SCIENTIFIC REPORTS (2014)
Nilotinib reverses loss of dopamine neurons and improves motor behavior via autophagic degradation of -synuclein in Parkinsons disease models
Michaeline L. Hebron et al.
HUMAN MOLECULAR GENETICS (2013)
Towards heterogeneous organocatalysis: chiral iminium cations supported on porous materials for enantioselective alkene epoxidation
Philip C. Bulman Page et al.
CATALYSIS SCIENCE & TECHNOLOGY (2013)
Amyloid-like Aggregates Sequester Numerous Metastable Proteins with Essential Cellular Functions
Heidi Olzscha et al.
CELL (2011)
Gold nanoparticles supported on TiO2 catalyse the cycloisomerisation/oxidative dimerisation of aryl propargyl ethers
Christina Efe et al.
CHEMICAL COMMUNICATIONS (2011)
Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test
Fabio S.L. da Conceição et al.
Jove-Journal of Visualized Experiments (2010)
Highly Enantioselective Total Synthesis of (-)-(3′S)-Lomatin and (+)-(3′S,4′R)-trans-Khellactone
Philip C. Bulman Page et al.
ORGANIC LETTERS (2009)
Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and α-synuclein-deleted mice
Daniel Alvarez-Fischer et al.
EXPERIMENTAL NEUROLOGY (2008)
Stages in the development of Parkinson's disease-related pathology
H Braak et al.
CELL AND TISSUE RESEARCH (2004)
Idiopathic Parkinson's disease:: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen
H Braak et al.
JOURNAL OF NEURAL TRANSMISSION (2003)
Staging of brain pathology related to sporadic Parkinson's disease
H Braak et al.
NEUROBIOLOGY OF AGING (2003)
Share Paper
